The John Marshall
Law School will be hosting a Hot Topics in Intellectual Property Law seminar
entitled "Myriad
Debrief: Biotechnology and Patents before Supreme Court" from 9:00 to
10:00 am (Central) on April 16, 2013 at the John Marshall Law School in
Chicago, IL. Patent Docs author Kevin
Noonan of McDonnell Boehnen Hulbert & Berghoff LLP will offer his insights
on this critical case and debrief attendees on the oral argument to be held on
April 15. Those interested in
registering for the seminar can do so here.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Recent Posts
- Metacel Pharmaceuticals LLC v. Rubicon Research Private Ltd. (Fed. Cir. 2025)
- Recentive Analytics, Inc. v. Fox Corp. (Fed. Cir. 2025)
- Sage Products, LLC v. Stewart (Fed. Cir. 2025)
- Recor Medical, Inc. v. Medtronic Ireland Mfg. (Fed. Cir. 2025)
- Newman v. Moore -- Down to a "Battle of the Experts"?
- Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (Fed. Cir. 2025)
- Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025)
- DNA Genotek Inc. v. Spectrum Solutions LLC (Fed. Cir. 2025)
- Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025)
- Five Years Ago Today . . .
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« IPO Webinar on Oral Argument in Myriad | Main | Conference & CLE Calendar »
April 14, 2013
The comments to this entry are closed.
April 2025
Categories
- Artificial Intelligence (19)
- Best Mode (2)
- Biosimilars (247)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (278)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (107)
- Conferences & CLE's (2977)
- Copyright (4)
- Court Report (507)
- Damages (37)
- Definiteness (27)
- District Court (223)
- Double Patenting (42)
- Enablement (53)
- Federal Circuit (1039)
- Food and Drug Administration (112)
- Hatch-Waxman (96)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (29)
- Infringement - Literal or DOE (92)
- Injunction (39)
- International IP (297)
- Inventorship (17)
- Licensing (129)
- Media Commentary (71)
- Miscellaneous (169)
- News from Abroad (102)
- Novelty (75)
- Obviousness (238)
- Patent Exhaustion (3)
- Patent Legislation (312)
- Patent Litigation (217)
- Patent Office Rules & Procedures (833)
- Patent Profiles (104)
- Patent Prosecution (99)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (371)
- Patentable Subject Matter (646)
- Personalized Medicine (5)
- Post-Grant Proceedings (158)
- PTAB Report (9)
- Study/Report (8)
- Supreme Court (265)
- Tools (5)
- Trade Secrets (13)
- Utility (4)
- Venue (11)
- Written Description (90)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Comments